Atlas Trials

Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)

Clinical trial NCT02088762 · COMPLETED

Trial details

NCT number
NCT02088762
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
COMPLETED
Study type
OBSERVATIONAL
Melanoma
Start date
1997-01-01
Primary completion
2012-12-01
Enrollment
325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.